Confirm Preclinical Programs Are IND-Ready

Independent, structured validation of targets, mechanisms, and translational risk before regulatory submission.

The Gap in Current Tools

Internal studies and predictive models do not independently confirm target-mechanism relationships or translational robustness.
Literature reviews and CRO reports may not detect conflicting signals from parallel research.

Highlights gaps or risks before costly IND submission.
Provides comparative metrics to evaluate novelty, reproducibility, and mechanism validity.

Cross-institutional, anonymised data aggregation surfaces signals, trends, and directional evidence unavailable to any single program.

Cross-institutional, anonymised reasoning layer aggregates signals, trends, and directional evidence.
Supports both regulatory readiness and strategic decision-making.

Commission your pre-IND readiness report before major CRO spend, regulatory prep, or KOL-facing narrative freeze.

Submit program context, targets, and mechanisms.
Report provides quantified validation of preclinical evidence and translational reliability.

Explore adjacent validation types within your decision workflow.

View all Biotech validation reports for the full cluster overview and internal navigation.

Strategic Audit

Independent scientific readiness assessment for IND-track programs. Structured validation before regulatory submission.